Clinical and Immune Impact of Mycobacterium bovis BCG Vaccination Scarring

The World Health Organization recommends Mycobacterium bovis BCG vaccination in areas of high tuberculosis prevalence. BCG's clinical and immune effects, not necessarily Mycobacterium tuberculosis specific, are unclear. BCG vaccine scarring often is used as a surrogate marker of vaccination or...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jason, Janine, Archibald, Lennox K., Nwanyanwu, Okey C., Kazembe, Peter N., Chatt, Julie A., Norton, Elizabeth, Dobbie, Hamish, Jarvis, William R.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2002
Matèries:
Microbial Immunity and Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC130324/
https://ncbi.nlm.nih.gov/pubmed/12379697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.70.11.6188-6195.2002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars